Date: 2026-02-22 Quarter: Q4 FY25 (ended Dec-25) Market cap: ~$1.0B | P/S (TTM): ~0.8x | Revenue growth: 20% YoY (Q4), 26% FY25
I haven't written about PGY specifically before. Applying my framework fresh.
Going into this, my baseline question is always: is the revenue growth durable? Pagaya is an AI-powered credit underwriting platform — B2B2C embedded in lender workflows. The interesting question is whether the business model is structurally sound enough to survive a credit cycle, and whether the growth trajectory has any chance of re-accelerating.
What I expected: a fintech company with cyclical exposure, probably growing 20-30%, with complex securitization structure. The valuation selloff post-earnings suggests the market saw something concerning.
The numbers have to match the theory. Here's what they say:
| Q1_23 | Q2_23 | Q3_23 | Q4_23 | Q1_24 | Q2_24 | Q3_24 | Q4_24 | Q1_25 | Q2_25 | Q3_25 | Q4_25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue ($m) [Non-GAAP basis / total revenue] | 186.6 | 195.6 | 211.8 | 218.0 | 245.0 | 250.0 | 257.0 | 279.4 | 290.0 | 326.0 | 350.0 | 335.0 |
| YoY % | — | — | — | — | +31% | +28% | +21% | +28% | +18% | +30% | +36% | +20% |
| QoQ % | — | +5% | +8% | +3% | +12% | +2% | +3% | +9% | +4% | +12% | +7% | -4% |
| Net Income ($m) [GAAP] | — | — | — | — | — | — | — | -237.9¹ | 8.0 | 17.0 | 23.0 | 34.0 |
| Adj EBITDA ($m) [Non-GAAP] | — | — | — | — | — | — | — | — | 80 | 86 | 107 | 98 |
| FRLPC ($m) | — | — | — | — | — | — | — | — | — | — | — | 131 |
| Network Volume ($B) | — | — | — | — | — | — | — | — | — | — | — | 2.7 |
¹ Q4_24 loss likely one-time impairment/writedown. FY25 is the true profitability inflection year.
Full Year:
| FY24 | FY25 | YoY% | |
|---|---|---|---|
| Revenue ($m) | $1,031 | $1,301 | +26% |
| Adj EBITDA ($m) [Non-GAAP] | $210 | $371 | +76% |
| Net Income ($m) [GAAP] | — | $81 | — |
| FRLPC ($m) | $406 | $512 | +26% |
| Network Volume ($B) | $9.6 | $10.5 | +9% |
The revenue growth arc is: 31% → 28% → 21% → 28% → 18% → 30% → 36% → 20%. The Q3 peak of 36% was real, driven by genuine volume acceleration. Then Q4 happened: revenue declined sequentially -4.3% and YoY decelerated from 36% to 20% in a single quarter.
Management's explanation: deliberate. They pulled back $100-150M in quarterly volume from higher-risk credit tiers due to "persistent consumer uncertainty." Three new partners (Achieve, Global Lending Services, major BNPL) were onboarded. ABS deals are oversubscribed 30%+.
The 2026 guide tells the real story: revenue 1.4 − 1.575B, midpoint 1.49B, implying ~15% growth from FY25's $1.3B.
15% is the critical number. That's not the trajectory of a growth company. That's the trajectory of a profitable financial technology business in a cautious credit environment.
| Belief | Going In | After Data | Change |
|---|---|---|---|
| Revenue growth durable? | Uncertain | No — decelerating to 15% guided | ↓ Negative |
| Business model quality? | Uncertain | Decent — B2B2C embedded, sticky partners | Neutral |
| GAAP profitability trajectory? | Uncertain | Positive — $81M FY25, accelerating | ↑ Positive |
| Credit cycle exposure? | High concern | Confirmed — management guided $100-150M impairment buffer | ↓ Negative |
| Valuation? | Likely cheap post-selloff | Very cheap — 0.8x TTM rev, ~8x fwd P/E | Neutral (but for a reason) |
Let me be clear about where this is actually interesting:
GAAP profitability is real and accelerating. $8M → $17M → $23M → $34M — four consecutive profitable quarters with clear upward trajectory on NI even as revenue wobbled. $81M for FY25. Guided $100-150M for FY26 — that's +23-85% NI growth on 15% revenue growth. The operating leverage is showing up.
FRLPC margin stable. At 4.8% Q4, roughly in line with the FY25 4.9% average. 2026 guidance of 4-5% isn't expanding, but it's not collapsing either. Management isn't destroying economics to chase volume.
ABS funding is strong. $8.5B raised in 2025, latest deal oversubscribed 30%. This is the oxygen the model needs. If the funding markets were shutting down, I'd be much more worried.
The pullback might actually be smart. Management voluntarily cutting $100-150M in quarterly volume from risky segments before credit deterioration shows up in numbers is exactly the right move. Most growth companies would have chased the volume and dealt with consequences later.
Valuation is genuinely cheap. 0.8x TTM revenue, ~8x forward P/E on a GAAP-profitable business. That's not a premium to unpack — that's outright cheap.
Revenue growth is decelerating to a level I can't classify as a growth company. 15% guidance for 2026. This is below my minimum threshold for growth investing. I need durable growth above 20-25% minimum to underwrite a growth thesis. Guided 15% doesn't get there.
The numbers expose a mixed picture on volume. Network volume grew only 9% FY25 vs 26% revenue growth. FRLPC grew 26% too — which means revenue growth was driven by monetization improvement, not volume expansion. That's fine until monetization maxes out. And volume declined in Q4 by design. If the "design" was actually necessity dressed up as choice, that's a red flag.
I don't have gross margins. Fintech models use FRLPC as a proxy — 4.8% of network volume, or implicitly the spread retained after production costs. This isn't comparable to software margins. The Atlas note points to a ~39% gross margin proxy. That fails my >70% gross margin preference for high-quality growth businesses.
Management quality signals are mixed. Glassdoor 3.2/5, 51% recommend, with explicit "toxic culture" and high turnover reviews. CEO framing around "becoming a better Pagaya, not just a bigger one" is either genuinely disciplined or a spin on disappointing growth. I can't tell which from here.
Credit impairment buffer in guidance is a yellow flag. Guiding $100-150M in credit-related impairments for 2026 is management telling you they expect losses. That's honest, but it also means the P&L could see significant hits even in the base case.
The Q4 network volume miss vs guidance. $2.7B vs $2.75-2.95B guided. Management missed their own Q4 volume target even after the "deliberate pullback" framing. That's a credibility question — if the pullback was intentional, why didn't guidance reflect it?
| Metric | FY25 Guide | FY25 Actual | Beat? |
|---|---|---|---|
| Network Volume | $10.5-10.75B | $10.5B | Lower end |
| Revenue | $1.30-1.325B | $1.301B | Lower end |
| Adj EBITDA | $372-382M | $371M [Non-GAAP] | Just below |
| GAAP NI | $72-82M | $81M [GAAP] | Beat |
FY25 as a whole: management delivered on revenue and NI, missed EBITDA slightly, and met volume at the floor. 2026 guidance is: network vol $11.25-13B (+15% midpoint from FY25), revenue $1.4-1.575B (+15%), EBITDA $410-460M (+17%), GAAP NI $100-150M (+54%).
The wide guidance range (vol: $11.25-13B, 15% spread) signals management uncertainty about credit conditions. A company confident in its trajectory gives a tighter range.
| Metric | Value | Assessment |
|---|---|---|
| Market Cap | ~$1.0B | — |
| P/S (TTM, $1.3B rev) | ~0.8x | Extremely cheap for any profitable tech |
| P/S (2026E midpoint) | ~0.7x | Cheaper still |
| P/E (TTM GAAP, $81M NI) | ~12x | Cheap for profitable company |
| Fwd P/E (2026E midpoint $125M) | ~8x | Deep value |
| EV/Adj EBITDA (TTM) | ~2.7x | Distressed valuation |
The valuation is undeniable. At 0.8x revenue and 8x forward earnings, the market is not paying for growth — it's paying for the possibility the business doesn't deteriorate further. That's a value setup, not a growth setup.
In other words: the market believes PGY's earnings power could be impaired by credit cycle stress. At 8x forward earnings, the margin of safety exists IF the credit thesis holds. If credit deteriorates, earnings could decline and the "cheap" multiple expands.
PGY is not a stock I'd own in a growth portfolio. The revenue growth is decelerating to 15% — that's below any growth threshold I apply. The business model has structural features I don't prefer: cyclical fintech exposure, complex securitization, opaque gross margins, no NRR or dollar-based net retention in the traditional sense.
What IS interesting: this is a profitable, cash-generating AI infrastructure business trading at genuinely distressed valuation multiples after a 47% post-earnings collapse. If you believed the credit cycle would be benign and the 2026 guide is conservative, the upside is real. But I don't invest based on hope, and "credit cycle will be fine" is exactly that.
The Atlas baseline is right: Conviction 2. This is a speculative value setup for investors who specialize in distressed financial turnarounds. That's not me.
The numbers have to match the theory. The theory here is "profitable AI lending platform massively undervalued due to credit fear." The numbers mostly support that — but revenue growth at 15% means the "growth" part of the story is behind us. I could be wrong. If credit conditions stabilize and PGY re-accelerates toward 20-25% growth, this looks very different at 0.8x revenue. But I'm not going to underwrite that scenario with a position.
Action: No position. Watch list only. Monitor FY26 Q1 results for volume trajectory and credit impairments. If volume growth ex-SFR re-accelerates and credit impairments come in below $100M, revisit.
Promises made (FY26):
Track: Q1 FY26 results (May 2026). First read on whether "deliberate pullback" leads to re-acceleration or further deceleration.
Bear